Tag: Psychedelic Therapies
Heroic Dose Event Explores Promise of Psychedelic Medicine for Veterans, Military & Servicemen and Women
Entheon Biomedical Corp. Launches HaluGen’s Psychedelics Genetic Test
Core One Labs Completes Acquisition of Ketamine Infusions Centers of Texas Representing the Company’s First Psychedelics Clinic in the U.S. and Announces Fast Entry Inclusion in the Horizons Psychedelic ETF
Empower Clinics Announces Receipt of Over $12,000,000 From Exercise of Warrants, Receives Full MDEL Status from Health Canada, Finalizes Lease Agreements for Initial Canadian Health Centers and Completes Lease for KAI Lab Expansion
Allied Files Provisional Patent for Psilocybin Therapeutic Invention Seeking Drug Indication for Mental Health Depression and Anxiety Applications
Pure Extracts Sells First Shipment of Cannabis Oil Extracts to German Pharma Company
Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Bioynthesized Psilocybin in Brazil
